How far away is out-of-autoclave aerostructure production for Airbus and Boeing?

Airbus and Boeing are converging on a shared conclusion: out-of-autoclave (OoA) production of large composite aerostructures—wings and fuselage barrels—for next-generation single-aisle jets is likely feasible, but probably a decade or more away from industrial maturity. The core constraint is straightforward but severe. Current autoclave curing, as used on the A350 and 787, is slow and capital-intensive—Bjorn Fehrm's analysis for LNA shows a full wing-cover cure cycle on the A350 takes 24 hours with only two covers fitting per chamber, requiring two dedicated production sites (Stade and Illescas) just to sustain roughly 10 airframes per month. Scaling that architecture to the 100-plus-aircraft-per-month rates both airframers want for their next narrowbody programs would require as many as 20 continuously running autoclaves—a cost and footprint neither company wants to bear. That math is the real driver behind the renewed research push into resin transfer molding and other OoA techniques, since the arithmetic of autoclave capacity simply doesn't scale to single-aisle production volumes.

For working pilots, this is a story about the next 10-15 years of fleet renewal rather than an immediate operational concern, but it matters because it directly shapes the timeline and design philosophy of the aircraft that will eventually replace the A320neo and 737 MAX families. Boeing's Lisa Orme has signaled that a next-gen narrowbody realistically won't enter service until the late 2030s or even 2040, and the autoclave bottleneck is a material reason why—not engine technology, not avionics, but the physical manufacturing limits of curing composite wings and fuselages at rate. Pilots transitioning types over the coming decades should expect that whatever eventually replaces today's narrowbodies will feature higher-aspect-ratio wings (Airbus is already flight-testing extended wingtips on an A321neo testbed), mixed material construction with composite spars and box structures paired with aluminum leading/trailing edges, and airframe architectures optimized as much for manufacturability as for aerodynamic performance. This mirrors lessons learned from the A350 and 787 programs, both of which delivered genuine efficiency gains but also encountered years of production-rate pain and quality-escape issues (notably Boeing's ongoing 787 fuselage-shimming and inspection saga) that neither manufacturer wants to repeat at narrowbody volumes.

The broader trend here is the industry's shift from "composites as a performance play" to "composites as a rate-production problem." During the A350/787 era, the industry accepted slow, expensive autoclave cycles because widebody production rates were inherently low—10-14 aircraft per month was tolerable. Single-aisle production, by contrast, is the volume backbone of both manufacturers' businesses, with combined A320neo/737 MAX output already exceeding 60-70 aircraft monthly and climbing toward triple digits as supply chains stabilize post-pandemic. Any next-gen narrowbody that leans heavily on composite primary structure must solve the rate problem before it solves the performance problem, which is why both companies are simultaneously pursuing higher-aspect-ratio wing aerodynamics (via Airbus's Wing of Tomorrow demonstrators) and parallel materials-science efforts to cure large structures without autoclaves. The 777X program, still working through certification, illustrates the interim compromise: a mostly composite wing that still relies on autoclave curing because production rates for large twin-aisles remain low enough to justify it.

For operators, lessors, and flight departments planning long-term fleet strategy, the practical takeaway is that the next narrowbody generation will arrive later than some earlier industry chatter suggested, and its design will be shaped as much by factory physics as by fuel-burn targets. Airlines banking on a clean-sheet 737/A320 successor in the early-to-mid 2030s should recalibrate expectations toward the back half of that decade at the earliest. In the meantime, expect continued incremental improvements to existing MAX and neo variants, further wingtip and winglet development, and growing use of OoA techniques on smaller components—door surrounds, brackets, secondary structure—as both manufacturers de-risk the technology before attempting to apply it to primary wing and fuselage structures at the rates their business models demand.